HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹280 Cr | ₹187 Cr | ₹315 Cr | ₹294 Cr | ₹229 Cr |
What is the latest Cash Flow from Operating Activities ratio of HIKAL ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹280 Cr |
| Mar2024 | ₹187 Cr |
| Mar2023 | ₹315 Cr |
| Mar2022 | ₹294 Cr |
| Mar2021 | ₹229 Cr |
How is Cash Flow from Operating Activities of HIKAL Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹280 Cr | 50.19 | |
| Mar2024 | ₹187 Cr | -40.79 | |
| Mar2023 | ₹315 Cr | 7.35 | |
| Mar2022 | ₹294 Cr | 28.26 | |
| Mar2021 | ₹229 Cr | - | |
Compare Cash Flow from Operating Activities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,392.0 Cr | -8.6% | -19.9% | -47.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -8.6% |
-19.9% |
-47.8% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses